Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Cellectar Biosciences, Inc. (CLRB)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -28.6-24.1-15.1-14.1-15.5-15.0-9.4-5.5
Depreciation and amortization  0.10.1 0.10.11.50.40.4
Asset impairment charges      1.7   
Stock-based compensation  1.51.10.50.90.70.80.50.4
Change in working capital   [+]12.38.55.79.3-0.50.70.32.8
Other operating activities  -10.5-8.2-5.0-7.92.01.0-0.1-6.3
Cash from operations  -25.2-22.6-13.9-11.7-11.4-11.0-8.3-8.2
   
Capital expenditures   [+]-0.2-0.1-0.10.0-0.4-0.3-0.1-0.1
Cash from investing  -0.2-0.1-0.10.0-0.3-0.3-0.1-0.1
   
Issuance of common stock, net  9.60.059.7 9.14.912.43.3
Financing costs        0.00.0
Other cash from financing   1.20.89.05.95.03.6-0.6
Cash from financing  9.61.260.59.015.09.915.92.7
   
Free cash flow  -25.4-22.7-14.0-11.7-11.8-11.4-8.4-8.3
        Per share (diluted)  ($3.61)($4.09)($0.71)($1.53)($3.99)($8.10)($1.91)($10.58)
   
Cash paid for interest    0.00.0 0.00.00.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy